ADP-ribosylation from molecular mechanisms to therapeutic implications
Cell · 2023-10 · 186 (21) · 4475-4495
DOI: 10.1016/j.cell.2023.08.030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell, 2023-10. Verfasst von Marcin J Suskiewicz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Biophysique Moléculaire, CNRS, Orléans, France. Hauptthemen laut MEDLINE: ADP-Ribosylation. Die Arbeit wurde bisher 223-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, Wellcome Trust, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre de Biophysique Moléculaire, CNRS, Orléans, France.
- Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
- Sir William Dunn School of Pathology, University of Oxford, Oxford, UK; MRC Centre of Medical Mycology, University of Exeter, Exeter, UK.
- Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. Electronic address: ivan.ahel@path.ox.ac.uk.
Förderung
- Department of Health
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Medical Research Council
Zitieren
APA
Suskiewicz, M. J., Prokhorova, E., Rack, J. G. M., & Ahel, I. (2023). ADP-ribosylation from molecular mechanisms to therapeutic implications. Cell, 186(21), 4475-4495. https://doi.org/10.1016/j.cell.2023.08.030
Vancouver
Suskiewicz MJ, Prokhorova E, Rack JGM, Ahel I. ADP-ribosylation from molecular mechanisms to therapeutic implications. Cell. 2023;186(21):4475-4495. doi:10.1016/j.cell.2023.08.030
BibTeX
@article{Suskiewicz2023,
author = {Suskiewicz, Marcin J and Prokhorova, Evgeniia and Rack, Johannes G M and Ahel, Ivan},
title = {ADP-ribosylation from molecular mechanisms to therapeutic implications},
journal = {Cell},
year = {2023},
volume = {186},
number = {21},
pages = {4475--4495},
doi = {10.1016/j.cell.2023.08.030}
}
EUVIMED